Clinical and Translational Science

Cover image for Vol. 7 Issue 4

Edited By: Arthur M. Feldman, MD, PhD

Impact Factor: 2.11

ISI Journal Citation Reports © Ranking: 2013: 65/122 (Medicine Research & Experimental)

Online ISSN: 1752-8062

News


Clinical and Translational Science is now indexed in MEDLINE and ISI! CTS has been awarded its first Impact Factor, 1.132, in the Medicine, Research, and Experimental category.

Free online access through 2011. View content online.

Following are the top five most-accessed articles in 2009 published in Clinical and Translational Science:

CTS: A New Discipline to Catalyze the Transfer of Information

Arthur M. Feldman, MD, PhD  
Vol. 1, No. 1, May 2008

Urinary Biomarkers for Sensitive and Specific Detection of Acute Kidney Injury in Humans 
Vishal S. Vaidya, Sushrut S. Waikar, Michael A. Ferguson, Fitz B. Collings, Kelsey Sunderland, Costas Gioules, Gary Bradwin, Roland Matsouaka, Rebecca A. Betensky, Gary C. Curhan, and Joseph V. Bonventre  
Vol. 1, No. 3, December 2008

Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes  
Allison B. Goldfine, Robert Silver, Waleed Aldhahi, Dongsheng Cai, Elizabeth Tatro, Jongsoon Lee, and Steven E. Shoelson  
Vol. 1, No. 1, May 2008

ErbB2 Induces Notch1 Activity and Function in Breast Cancer Cells 
Jaime Lindsay, Ph.D., Xuanmao Jiao, Ph.D., Toshiyuki Sakamaki, Ph.D., Mathew C. Casimiro, Ph.D., Lawrence A. Shirley, M.D., Thai H. Tran, Ph.D., Xiaoming Ju, M.D., Manran Liu, Ph.D., Zhiping Li, M.D., Ph.D., Chenguang Wang, Ph.D., Sanjay Katiyar, Ph.D., Mahadev Rao, Ph.D., Kathleen G. Allen, M.D., Robert I. Glazer, Ph.D., Changhui Ge, Ph.D., Pamela Stanley, Ph.D., Michael P. Lisanti, M.D., Ph.D., Hallgeir Rui, M.D., Ph.D., and Richard G. Pestell, M.D., Ph.D.  
Vol. 1, No. 2, September 2008

Sunitinib-Induced Cardiotoxicity Is Mediated by Off-Target Inhibition of AMP-Activated Protein Kinase  
Risto Kerkela, Kathleen C. Woulfe, Jean-Bernard Durand, Ronald Vagnozzi, David Kramer, Tammy F. Chu, Cara Beahm, Ming Hui Chen, and Thomas Force  
Vol. 2, No. 1, February 2009

STUDY FINDS ANTI-INFLAMMATORY MEDICATION MAY TREAT TYPE 2 DIABETES: Builds on earlier study that showed inexpensive drug may also prevent the disease

BOSTON - May 22, 2008 - Researchers at the Joslin Diabetes Center who reported earlier this year that an inexpensive, non-steroidal anti-inflammatory drug called salsalate might prevent type 2 diabetes are now reporting that the drug may also be beneficial in the treatment of the disease.
 
The paper, which appears in the May 2008 issue of the journal Clinical and Translational Science (CTS), reports on three proof-of-concept studies that demonstrate that salsalate, which has been used for decades to treat arthritis, may benefit patients with type 2 diabetes by lowering blood sugar and reducing inflammation.

Click here for FREE access to this study

NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate,  please visit our policy statement. 

 

SEARCH

SEARCH BY CITATION